After Hours Summary: FDA approves boosters for JNJ and Moderna; IBM -4.2% falls on earnings; TSLA -0.6% roughly flat on earnings; TSC jumps +27.5% on deal to be acquired by RJFAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: XM +5.7%, SLM +4.1% (also approves $250 mln increase to share repurchase program and increases dividend), HPQ +3.8% (reaffirms FY21 EPS guidance; issues upside FY22 EPS guidance; raises annual dividend 29% to $1/sh), CSX +2.9%, THC +2.2%, LSTR +1.8%, SEIC +0.3%, CNS +0.2%, FR +0.1%
Companies trading higher in after hours in reaction to news: TSC +27.5% (TSC to be acquired by RJF in cash and stock deal worth $1.1 bln), CNI +1.7% (Elliot Mgmt has a big stake, according to WSJ), MRNA +1.6% (FDA approves booster dose for JNJ and Moderna vaccines, and allows for mixing and matching), CRNX +1.5% (stock offering), UNIT +1.4% (Zayo Group seeking to acquire UNIT, according to WSJ), JNJ +0.8% (FDA approves booster dose for JNJ and Moderna vaccines, and allows for mixing and matching), MMP +0.2% (approves additional $750 mln equity repurchase authorization and increases quarterly distribution), PFE +0.2% (CDC advisory committee votes to recommend routine use of PREVNAR 20 in adults)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CVLG -6.5%, KALU -6.1%, UMPQ -6%, FTI -4.6%, GGG -4.5%, IBM -4.2%, LRCX -2.4%, KMI -2.2% (also increases dividend), LVS -2.1%, TCBI -2%, OMF -1.6%, CCI -1.5% (also increases dividend), PPG -1.5%, DFS -0.8%, TSLA -0.6%, VMI -0.2%, SLG -0.1%
Companies trading lower in after hours in reaction to news: ZLAB -12% (announces topline results from Phase 1b study of ZL-1102 for chronic plaque psoriasis), ADMA -8.1% (stock offering), GOCO -2.1% (current CFO to transition to CTO role; looking for new CFO), CNK -0.2% (announces digital innovations to enhance guest experience), REGN -0.1% (REGN and SNY announce expanded FDA approval of Dupixent to include children with asthma